ARCHIVES

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

July 26, 2013

Pitot Named New NCAB Chairman

May 4, 1979

DeVita Changes Mind On OSP Phase Out Reasons, But Presses for “Internalizing” Coordinating Portfolio

January 1, 1988

Lower Stomach Cancers Increasing In Younger U.S. Whites, Study Finds

May 28, 2010

IOM Report Lists Cancer CER Priorities

July 3, 2009

NIH Bias Against Young Investigators Threatens To “Deprime The Pump,” Zerhouni Says.

February 15, 2008